ALGIERS, Algeria and AMMAN, Jordan, Jan. 26, 2026 /PRNewswire/ -- MS Pharma Group, a leading regional pharmaceutical company in the MENA region, has signed a strategic partnership agreement with ...
Kashiv BioSciences and MS Pharma have entered into a license and supply agreement for ADL-018, Kashiv BioSciences’ biosimilar candidate to Genentech and Novartis AG’s Xolair (omalizumab) in the Middle ...
MS Pharma becomes Partner for the Commercialization of FYB201, Formycon's Biosimilar Candidate to Lucentis(R)1 (ranibizumab), in the MENA Region 14.12.2021 / 08:00 The issuer is solely responsible for ...
PLANEGG-MARTINSRIED, Germany and AMMAN, Jordan, Dec. 4, 2025 /PRNewswire/ -- Formycon AG (FSE: FYB, Prime Standard) and MS Pharma jointly announce that they have entered into an exclusive licensing ...
RIYADH, Saudi Arabia, Aug. 27, 2025 /PRNewswire/ -- MS Pharma has officially inaugurated the first biologics' manufacturing facility in the Middle East, strategically located in Saudi Arabia. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results